Healthcare Nova

The only information source for private healthcare services in Emerging Markets, click here to download a brochure

Reports

HealthcareNova - Reports: White Paper

Universal health coverage and private health care: Friends or foes?

Universal Health Coverage is now explicitly targeted by the third sustainable development goal set out by the United Nations. Increasingly, governments around the world want to offer it to their citizenry. Where the capacity will come from is less certain. In... [+]

MBAs and executive training courses – are they worth the time and money?

You can’t become an expert in healthcare services overnight - but there are courses, MBAs or much shorter executive training courses - which say they can help to transform you or your staff into the next generation of healthcare managers, leaders and entrepreneurs. But can they really do this - and are they good value for money? Where should you send yourself, or your staff, to fill any gaps in knowledge that might be putting the brakes on a career? And does it matter if the management course isn’t focussed on healthcare at all?

Spotlight on labs: India and Brazil

We look at labs in India, and profile the big lab and imaging groups in Brazil. Future articles will also look at the sector in China and across SE Asia and Africa.

The future of healthcare in Nigeria: PPPs and the NHIS?

Healthcare investors generally take a fancy to Nigeria. Africa’s most populous country has a growing middle class and will one day finally put some distance between itself and South Africa as its largest economy. The petrodollars already flow freely into healthcare. But no one has bothered to keep them in the country: not the existing fragmented private sector, nor the government, which has other priorities – President Buhari has been treated in London, after all! So, surely, all that’s left to do is fly in, start a JV with a local partner, consolidate and cut off the medical tourism leak at source?

Latam countries thriving despite recession

Despite, or perhaps because of the recession, prospects for private healthcare services in Latin America are good. The financial crisis in public healthcare is forcing governments to rethink attitudes to the private sector and to open up the sector to external investors. And new, innovative models are emerging. In this 6,000 word report we give a detailed analysis of the six main markets – Brazil, Mexico, Argentina, Chile, Peru and Colombia, and over the next few days we'll be profiling those major players, country by country.

Universal health coverage and private health care: Friends or foes?

Universal Health Coverage is now explicitly targeted by the third sustainable development goal set out by the United Nations. Increasingly, governments around the world want to offer it to their citizenry. Where the capacity will come from is less certain. In this report, Healthcare Nova asks experts at the forefront of UHC schemes from India to Mexico, where UHC is today and what role the private sector should play in extending healthcare access to the poor?

Private insurers in East Asia: Between a rock and a hard place

Private medical insurers face colossal problems in China, India and across South East Asia. At this month’s Asia Healthcare Summit in Singapore, they were better at describing the challenges of culture, fraud and overtreatment than they were at coming up with solutions.

KPMG report: Global trends in aged care

In its Global trends in aged care report, KPMG identifies five key themes that are likely to shape the elderly care market - based on interviews with experts in 20 countries.

Rating and booking sites: Threats or Friends?

There are growing signs that a new generation of rating and booking websites will change the face of outpatient care in many Emerging Markets. New players, sometimes backed by hundreds of millions of dollars, are investing in telehealth platforms that promise instant access to patients, partnering with pharmacies and making access to healthcare easier for patients. Some are active in dozens of countries. Here we talk to the major players about their strategies and how they see the market.

So what really happened at Bupa?

After four years, in which he transformed Bupa with a £1.8bn M&A drive, the company announced that CEO Stuart Fletcher is to leave after failing to meet expectations. His departure follows 2015 results which saw a fall of pre-tax profits of 39% to £347m. Where does that leave his plans to build an international brand with strengths in services as well as insurance? What really went wrong? With 2015 sales of £9.8bn, Bupa still has heft. Outside the USA, it remains one of the two largest international private medical insurers, the largest international dentistry player, one of the largest care home groups and, probably, the largest player in outpatient care – certainly the only one with scale in four continents.